Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1988 Dec;9:58–61.

Molecular analysis of Philadelphia chromosome positive leukaemias.

B D Young 1
PMCID: PMC2149126  PMID: 3076066

Full text

PDF
58

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartram C. R., Carbonell F. bcr rearrangement in Ph-negative CML. Cancer Genet Cytogenet. 1986 Mar 15;21(2):183–184. doi: 10.1016/0165-4608(86)90046-4. [DOI] [PubMed] [Google Scholar]
  2. Bartram C. R., Kleihauer E., de Klein A., Grosveld G., Teyssier J. R., Heisterkamp N., Groffen J. C-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J. 1985 Mar;4(3):683–686. doi: 10.1002/j.1460-2075.1985.tb03683.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartram C. R. bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia. J Exp Med. 1985 Dec 1;162(6):2175–2179. doi: 10.1084/jem.162.6.2175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ben-Neriah Y., Daley G. Q., Mes-Masson A. M., Witte O. N., Baltimore D. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science. 1986 Jul 11;233(4760):212–214. doi: 10.1126/science.3460176. [DOI] [PubMed] [Google Scholar]
  5. Boyd C. N., Ramberg R. C., Thomas E. D. The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res. 1982;6(6):833–837. doi: 10.1016/0145-2126(82)90067-4. [DOI] [PubMed] [Google Scholar]
  6. Chan L. C., Karhi K. K., Rayter S. I., Heisterkamp N., Eridani S., Powles R., Lawler S. D., Groffen J., Foulkes J. G., Greaves M. F. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature. 1987 Feb 12;325(6105):635–637. doi: 10.1038/325635a0. [DOI] [PubMed] [Google Scholar]
  7. Clark S. S., McLaughlin J., Crist W. M., Champlin R., Witte O. N. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science. 1987 Jan 2;235(4784):85–88. doi: 10.1126/science.3541203. [DOI] [PubMed] [Google Scholar]
  8. De Klein A., Hagemeijer A., Bartram C. R., Houwen R., Hoefsloot L., Carbonell F., Chan L., Barnett M., Greaves M., Kleihauer E. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood. 1986 Dec;68(6):1369–1375. [PubMed] [Google Scholar]
  9. Erikson J., Griffin C. A., ar-Rushdi A., Valtieri M., Hoxie J., Finan J., Emanuel B. S., Rovera G., Nowell P. C., Croce C. M. Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1807–1811. doi: 10.1073/pnas.83.6.1807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fialkow P. J., Martin P. J., Najfeld V., Penfold G. K., Jacobson R. J., Hansen J. A. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood. 1981 Jul;58(1):158–163. [PubMed] [Google Scholar]
  11. Ganesan T. S., Min G. L., Goldman J. M., Young B. D. Molecular analysis of relapse in chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood. 1987 Sep;70(3):873–876. [PubMed] [Google Scholar]
  12. Ganesan T. S., Rassool F., Guo A. P., Th'ng K. H., Dowding C., Hibbin J. A., Young B. D., White H., Kumaran T. O., Galton D. A. Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia. Blood. 1986 Oct;68(4):957–960. [PubMed] [Google Scholar]
  13. Geisler C., Plesner T., Ralfkiaer E., Larsen J. K., Hansen M. M. Cell markers in lymphoproliferative disease. Lancet. 1984 Dec 15;2(8416):1394–1394. doi: 10.1016/s0140-6736(84)92083-x. [DOI] [PubMed] [Google Scholar]
  14. Groffen J., Stephenson J. R., Heisterkamp N., de Klein A., Bartram C. R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984 Jan;36(1):93–99. doi: 10.1016/0092-8674(84)90077-1. [DOI] [PubMed] [Google Scholar]
  15. Jeffreys A. J., Wilson V., Thein S. L. Hypervariable 'minisatellite' regions in human DNA. Nature. 1985 Mar 7;314(6006):67–73. doi: 10.1038/314067a0. [DOI] [PubMed] [Google Scholar]
  16. Jeffreys A. J., Wilson V., Thein S. L. Individual-specific 'fingerprints' of human DNA. Nature. 1985 Jul 4;316(6023):76–79. doi: 10.1038/316076a0. [DOI] [PubMed] [Google Scholar]
  17. Kurzrock R., Shtalrid M., Romero P., Kloetzer W. S., Talpas M., Trujillo J. M., Blick M., Beran M., Gutterman J. U. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature. 1987 Feb 12;325(6105):631–635. doi: 10.1038/325631a0. [DOI] [PubMed] [Google Scholar]
  18. Kurzrock R., Shtalrid M., Talpaz M., Kloetzer W. S., Gutterman J. U. Expression of c-abl in Philadelphia-positive acute myelogenous leukemia. Blood. 1987 Nov;70(5):1584–1588. [PubMed] [Google Scholar]
  19. Lee M. S., Chang K. S., Cabanillas F., Freireich E. J., Trujillo J. M., Stass S. A. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science. 1987 Jul 10;237(4811):175–178. doi: 10.1126/science.3110950. [DOI] [PubMed] [Google Scholar]
  20. Leibowitz D., Schaefer-Rego K., Popenoe D. W., Mears J. G., Bank A. Variable breakpoints on the Philadelphia chromosome in chronic myelogenous leukemia. Blood. 1985 Jul;66(1):243–245. [PubMed] [Google Scholar]
  21. Liu E., Hjelle B., Bishop J. M. Transforming genes in chronic myelogenous leukemia. Proc Natl Acad Sci U S A. 1988 Mar;85(6):1952–1956. doi: 10.1073/pnas.85.6.1952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marmont A., Frassoni F., Bacigalupo A., Podestá M., Piaggio G., Van Lint M. T., Caimo A., de Filippi S. Recurrence of Ph'-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. N Engl J Med. 1984 Apr 5;310(14):903–906. doi: 10.1056/NEJM198404053101408. [DOI] [PubMed] [Google Scholar]
  23. Morris C. M., Reeve A. E., Fitzgerald P. H., Hollings P. E., Beard M. E., Heaton D. C. Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia. Nature. 1986 Mar 20;320(6059):281–283. doi: 10.1038/320281a0. [DOI] [PubMed] [Google Scholar]
  24. Popenoe D. W., Schaefer-Rego K., Mears J. G., Bank A., Leibowitz D. Frequent and extensive deletion during the 9,22 translocation in CML. Blood. 1986 Nov;68(5):1123–1128. [PubMed] [Google Scholar]
  25. Pugh W. C., Pearson M., Vardiman J. W., Rowley J. D. Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment. Br J Haematol. 1985 Jul;60(3):457–467. doi: 10.1111/j.1365-2141.1985.tb07443.x. [DOI] [PubMed] [Google Scholar]
  26. Rodenhuis S., Smets L. A., Slater R. M., Behrendt H., Veerman A. J. Distinguishing the Philadelphia chromosome of acute lymphoblastic leukemia from its counterpart in chronic myelogenous leukemia. N Engl J Med. 1985 Jul 4;313(1):51–52. doi: 10.1056/NEJM198507043130117. [DOI] [PubMed] [Google Scholar]
  27. Rowley J. D. Human oncogene locations and chromosome aberrations. Nature. 1983 Jan 27;301(5898):290–291. doi: 10.1038/301290a0. [DOI] [PubMed] [Google Scholar]
  28. Rowley J. D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973 Jun 1;243(5405):290–293. doi: 10.1038/243290a0. [DOI] [PubMed] [Google Scholar]
  29. Schaefer-Rego K., Dudek H., Popenoe D., Arlin Z., Mears J. G., Bank A., Leibowitz D. CML patients in blast crisis have breakpoints localized to a specific region of the BCR. Blood. 1987 Aug;70(2):448–455. [PubMed] [Google Scholar]
  30. Schwartz D. C., Cantor C. R. Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell. 1984 May;37(1):67–75. doi: 10.1016/0092-8674(84)90301-5. [DOI] [PubMed] [Google Scholar]
  31. Shtivelman E., Gale R. P., Dreazen O., Berrebi A., Zaizov R., Kubonishi I., Miyoshi I., Canaani E. bcr-abl RNA in patients with chronic myelogenous leukemia. Blood. 1987 Mar;69(3):971–973. [PubMed] [Google Scholar]
  32. Shtivelman E., Lifshitz B., Gale R. P., Roe B. A., Canaani E. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell. 1986 Oct 24;47(2):277–284. doi: 10.1016/0092-8674(86)90450-2. [DOI] [PubMed] [Google Scholar]
  33. Stam K., Heisterkamp N., Reynolds F. H., Jr, Groffen J. Evidence that the phl gene encodes a 160,000-dalton phosphoprotein with associated kinase activity. Mol Cell Biol. 1987 May;7(5):1955–1960. doi: 10.1128/mcb.7.5.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tachibana N., Raimondi S. C., Lauer S. J., Sartain P., Dow L. W. Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 1987 Nov;70(5):1458–1461. [PubMed] [Google Scholar]
  35. Thomas E. D., Clift R. A., Fefer A., Appelbaum F. R., Beatty P., Bensinger W. I., Buckner C. D., Cheever M. A., Deeg H. J., Doney K. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med. 1986 Feb;104(2):155–163. doi: 10.7326/0003-4819-104-2-155. [DOI] [PubMed] [Google Scholar]
  36. Travis L. B., Pierre R. V., DeWald G. W. Ph1-negative chronic granulocytic leukemia: a nonentity. Am J Clin Pathol. 1986 Feb;85(2):186–193. doi: 10.1093/ajcp/85.2.186. [DOI] [PubMed] [Google Scholar]
  37. Turhan A. G., Eaves C. J., Kalousek D. K., Eaves A. C., Humphries R. K. Molecular analysis of clonality and bcr rearrangements in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 1988 May;71(5):1495–1498. [PubMed] [Google Scholar]
  38. Walker L. C., Ganesan T. S., Dhut S., Gibbons B., Lister T. A., Rothbard J., Young B. D. Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. 1987 Oct 29-Nov 4Nature. 329(6142):851–853. doi: 10.1038/329851a0. [DOI] [PubMed] [Google Scholar]
  39. Westbrook C. A., Rubin C. M., Le Beau M. M., Kaminer L. S., Smith S. D., Rowley J. D., Diaz M. O. Molecular analysis of TCRB and ABL in a t(7;9)-containing cell line (SUP-T3) from a human T-cell leukemia. Proc Natl Acad Sci U S A. 1987 Jan;84(1):251–255. doi: 10.1073/pnas.84.1.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wiedemann L. M., Karhi K. K., Shivji M. K., Rayter S. I., Pegram S. M., Dowden G., Bevan D., Will A., Galton D. A., Chan L. C. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases. Blood. 1988 Feb;71(2):349–355. [PubMed] [Google Scholar]
  41. Wiedemann L. M., Karhi K., Chan L. C. Similar molecular alterations occur in related leukemias with and without the Philadelphia chromosome. Haematol Blood Transfus. 1987;31:149–152. doi: 10.1007/978-3-642-72624-8_32. [DOI] [PubMed] [Google Scholar]
  42. de Klein A., van Agthoven T., Groffen C., Heisterkamp N., Groffen J., Grosveld G. Molecular analysis of both translocation products of a Philadelphia-positive CML patient. Nucleic Acids Res. 1986 Sep 11;14(17):7071–7082. doi: 10.1093/nar/14.17.7071. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES